Skip to contents
Robert J. Glynn, Ph.D.
Biostatistician, Brigham and Women's Hospital
Professor of Medicine, Harvard Medical School

Brigham and Women's Hospital
Department of Medicine
Preventive Medicine
75 Francis Street
Boston, MA 02115

Edit Profile

Brandeis University, 1978, Ph.D.

Publications (Pulled from Harvard Catalyst Profiles):

1. Wang SV, Rogers JR, Jin Y, DeiCicchi D, Dejene S, Connors JM, Bates DW, Glynn RJ, Fischer MA. Stepped-wedge randomised trial to evaluate population health intervention designed to increase appropriate anticoagulation in patients with atrial fibrillation. BMJ Qual Saf. 2019 Jun 26.

2. Gordon WJ, Wright A, Glynn RJ, Kadakia J, Mazzone C, Leinbach E, Landman A. Evaluation of a mandatory phishing training program for high-risk employees at a US healthcare system. J Am Med Inform Assoc. 2019 Jun 01; 26(6):547-552.

3. Akinkuolie AO, Lawler PR, Chu AY, Caulfield M, Mu J, Ding B, Nyberg F, Glynn RJ, Ridker PM, Hurt-Camejo E, Chasman DI, Mora S. Group IIA Secretory Phospholipase A2, Vascular Inflammation, and Incident Cardiovascular Disease. Arterioscler Thromb Vasc Biol. 2019 Jun; 39(6):1182-1190.

4. Yoshida K, Solomon DH, Haneuse S, Kim SC, Patorno E, Tedeschi SK, Lyu H, Hernández-Díaz S, Glynn RJ. A tool for empirical equipoise assessment in multigroup comparative effectiveness research. Pharmacoepidemiol Drug Saf. 2019 Jul; 28(7):934-941.

5. Glynn RJ, Colditz GA, Tamimi RM, Chen WY, Hankinson SE, Willett WW, Rosner B. Comparison of Questionnaire-Based Breast Cancer Prediction Models in the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev. 2019 Jul; 28(7):1187-1194.

6. Bykov K, Schneeweiss S, Glynn RJ, Mittleman MA, Gagne JJ. A Case-Crossover-Based Screening Approach to Identifying Clinically Relevant Drug-Drug Interactions in Electronic Healthcare Data. Clin Pharmacol Ther. 2019 Jul; 106(1):238-244.

7. Everett BM, Cornel JH, Lainscak M, Anker SD, Abbate A, Thuren T, Libby P, Glynn RJ, Ridker PM. Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure. Circulation. 2019 Mar 05; 139(10):1289-1299.

8. Bykov K, Mittleman MA, Glynn RJ, Schneeweiss S, Gagne JJ. The Case-Crossover Design for Drug-Drug Interactions: Considerations for Implementation. Epidemiology. 2019 03; 30(2):204-211.

9. Yoshida K, Solomon DH, Haneuse S, Kim SC, Patorno E, Tedeschi SK, Lyu H, Franklin JM, Stürmer T, Hernández-Díaz S, Glynn RJ. Multinomial Extension of Propensity Score Trimming Methods: A Simulation Study. Am J Epidemiol. 2019 Mar 01; 188(3):609-616.

10. Gordon WJ, Wright A, Aiyagari R, Corbo L, Glynn RJ, Kadakia J, Kufahl J, Mazzone C, Noga J, Parkulo M, Sanford B, Scheib P, Landman AB. Assessment of Employee Susceptibility to Phishing Attacks at US Health Care Institutions. JAMA Netw Open. 2019 Mar 01; 2(3):e190393.